Y Liu, J Tong, X Fan, Y Xing - Available at SSRN 4720290 - papers.ssrn.com
Abstract PLK4 (polo-like kinase 4), an enzyme regulating centrioles, has been identified as a
highly promising target for cancer treatment, making the development of PLK4 inhibitors …